Health Condition 1: M190- Primary osteoarthritis of other joints
Conditions
Interventions
Intervention1: Ultrasound guided facet joint injection: 1% lignocaine and 40 mg depot methylprednisolone injection will be given at painful unilateral facet joint in low back area under ultrasound gui
Sponsors
All India institute of medical sciences Rishikesh
Eligibility
Inclusion criteria
Inclusion criteria: 1. Chronic LBP with or without proximal non-radicular extremity pain 2. Duration of pain at least more than 3 months 3. Pain unresponsive to conservative treatment including medical management, physical therapy, and previous interventions. 4. Average pain score of �4 on an 11-point NRS.
Exclusion criteria
Exclusion criteria: 1. Patient refusal 2. more than one facet joint or bilateral facet joint involvement 3. Pain for less than 3 months 4. Coagulopathy and/or patients on anticoagulants. 5. Infection at the site of injection. 6. Hypersensitivity to local anesthetic agent. 7. Evidence of significant progressive sensory or motor deficit, cauda-equina syndrome, H/O trauma, infection and cancer (Red flag signs). 8. Evidence of severe psychiatric illness. 9. History of spinal tumor, spinal cord injury or previous backs surgery 10.History of any major comorbid medical conditions, those interfere with recording of study outcomes (neurological disorders, auto-immune diseases), multiple sclerosis, and pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score [11-point numeric rating scale (NRS 11) score] in both the groupsTimepoint: 1 week, 1 month, 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. GPE (Global Perceived Effect) as measured by Likert scale 7-point scoring system to assess patient satisfaction and improvement. 2. Improvement in functional status as measured by Ronald Morris Questionnaire at respective time intervals. 3. Successful outcomes were defined as patients with ââ?°Â¥50% or ââ?°Â¥ 4 points reduction in NRS score and ââ?°Â¥50% or ââ?°Â¥6 points improvement in GPE (Global Perceived Effect) will be calculated. 4. Performance time will be recorded. For the US guidance, performance time is defined as the time interval between the point of contact of the US probe with the patientââ?¬â?¢s skin and the completion of the injectate. For FL guidance, performance time is defined as the temporal interval between the first radiographic image and the end of the injection. 5. Procedural complications (if any) Timepoint: 1 week, 1 month, 3 months | — |
Countries
India
Contacts
Public ContactDr Sonal Goyal
All India institute of medical sciences Rishikesh
Outcome results
None listed